Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 10 putative open reading frame 55 (C10orf55) encodes an uncharacterized protein in humans[13][1][9]. It shows identical protein binding activity but its specific molecular or cellular function remains unknown[1][4][11][13]. C10orf55 is classified as a putative gene product of unknown function and does not belong to known major target classes such as receptor, enzyme, ion channel, transporter, or transcription factor[4][1]. Its expression has been explored in certain disease contexts, such as Quebec Platelet Disorder and Alzheimer Disease 2, but there is currently no evidence that it represents a validated or exploited therapeutic target, nor that drugs are known to interact directly with this molecule[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 10 putative open reading frame 55 (C10orf55).